The forecast for antiinfective medicine sales in the UK from 2024 to 2028 shows a consistent increase. The value in 2023 stood at 67.00 US Dollars PPP Per Capita. The year-on-year growth indicates a steady increase:
- 2024: 68.47 US Dollars PPP Per Capita (increase from 2023)- 2025: 69.97 US Dollars PPP Per Capita (2.19% increase from 2024)- 2026: 71.44 US Dollars PPP Per Capita (2.10% increase from 2025)- 2027: 72.88 US Dollars PPP Per Capita (2.02% increase from 2026)- 2028: 74.29 US Dollars PPP Per Capita (1.93% increase from 2027)
The average compound annual growth rate (CAGR) over the next five years is approximately 2.06%.
Future trends to watch for include the impact of new regulatory policies, advances in antimicrobial treatments, and potential shifts in healthcare funding. Monitoring these factors will be key to anticipating future sales performance in the antiinfective segment.
